Caveolin 3 Antikörper

Produktnummer ABIN7266157

Produktdetails anti-Caveolin 3 Antikörper

Target: Caveolin 3 (CAV3)

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser Caveolin 3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Verwendungszweck: Caveolin-3 Rabbit mAb

Kreuzreaktivität: Human, Maus, Ratte

Produktmerkmale: Monoclonal Antibodies

Aufreinigung: Affinity purification

Immunogen: A synthesized peptide derived from human Caveolin-3

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB,1:500 - 1:2000,IHC,1:50 - 1:200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu Caveolin 3

Target: Caveolin 3 (CAV3)

Andere Bezeichnung: CAV3 (CAV3 Produkte)

Synonyme: LGMD1C antikoerper, LQT9 antikoerper, VIP-21 antikoerper, VIP21 antikoerper, AI385751 antikoerper, Cav-3 antikoerper, M-cav antikoerper, caveolin-3 antikoerper, im:6902906 antikoerper, zgc:109710 antikoerper, LOC733765 antikoerper, CAV3 antikoerper, cav3 antikoerper, caveolin 3 antikoerper, caveolin-3 antikoerper, CAV3 antikoerper, Cav3 antikoerper, cav3 antikoerper, LOC733765 antikoerper, cav-3 antikoerper

Hintergrund: This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008],LGMD1C, LQT9, VIP-21, VIP21,Endocrine & Metabolism,ErbB-HER Signaling Pathway,Insulin Receptor Signaling Pathway,Signal Transduction,CAV3

Molekulargewicht: 17kDa

Gen-ID: 859

UniProt: P56539

Pathways: Carbohydrate Homeostasis, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Negative Regulation of Transporter Activity